González-Huezo MS, Villela LM, Zepeda-Florencio MC, Carrillo-Ponce CS, Mondragón-Sánchez RJ

Language: English
References: 12
Page: 166-169
PDF size: 138.48 Kb.

Text Extraction

Introduction: Nodular regenerative hyperplasia (NRH) is a rare condition is associated to immune, neoplastic, vascular disorders, and certain drugs and toxins. Portal hypertension is the main complication. Aim: To report the case of a woman with NRH and aplastic anemia, association not previously described. Case: A 31-year-old hispanic female presented with pancitopenia and cholestasis. Bone marrow biopsy: aplastic anemia. Abdominal ultrasound revealed multiple liver nodules, without hepato-splenomegaly. No abnormalities were noted in hepatic vessels. Antimitochondrial (AMAs) were positive. Coagulation tests were normal. Liver biopsy: hepatocite nodules with central atrophy and sinusoidal dilatation in the absence of significant fibrosis. No arteritis, thrombosis or bile duct damage was found. Discussion: Pathogenesis of NRH remains unclear. The most accepted theory was developed by Wanless 24 years ago, and reinforced in 1997. It states that alterations in hepatic blood flow (portal obliterative venopathy) originate a specific response, initially consisting of apoptosis secondary to acute ischemia, with ensuing parenchymal atrophy and surrounding areas of liver regeneration and chronic ischemia. The common pathologic mechanism of all the diseases associated with NRH involves liver blood-flow abnormalities secondary to microthromboses, vascular congestion, or vasculitis. In the current case we were unable to document evidence of liver flow abnormalities. Noteworthy, there are previous descriptions of the association of NRH with primary biliary cirrhosis, and this patient was AMA positive, but without bile duct damage in liver biopsy. Conclusions: We cannot sustain Wanless’ theory, and this is the first description of the association of NRH with aplastic anemia.

REFERENCES

1. Wanless IR, Godwin TA, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematological disorders: A possible response to obliterative portal venopathy. A morphometric study of nine cases with a hypothesis on the patogenesis. Medicine 1980; 59: 367-379.

2. Terminology of Nodular Hepatocellular Lesions, International Working Party. Hepatology 1995; 22: 983-992.

3. Perez-Ruiz F, Orte FJ, Zea AC, et al. Nodular regenerative hyperplasia of the liver in rheumatic diseases: report of seven cases and review of the literature. Semin Arthritis Rheum 1991; 21: 47-54.

4. Cohen M, Ginsburg W, Allen G. Nodular regenerative hyperplasia of the liver and bleeding esophageal varices in Felty’s syndrome. J Rheumatol 1982; 9: 716-718.

5. Harris M, Rash RM, Dymock IW. Nodular noncirrhotic liver associated with portal hypertension in a patient with rheumatoid arthritis. J Clin Pathol 1974; 27: 963-966.

6. Matsumoto T, Kobayashi S, Shimizu H, et al. The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 2000; 20: 366-373.

7. Cancado ELR, Machado MD, Mitiko DM, et al. Celiac Disease associated with Nodular Regenerative Hyperplasia, Pulmonar abnormalities, and IgA Anticardiolipin Antibodies. J Clin Gastroenterol 2006; 40: 135-139.

8. Wanless IR, Peterson P, Das A, Biotnott JK, Moore GW, Bernier V. Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: A clinicopathological study of 145 patients examined at autopsy. Hepatology 1990; 12: 1166-1174.

9. Stenberg’s Diagnostic Surgical Pathology, 4th ed, 2004. Lippincot Williams and Wilkins, pp 1719-1921.

10. Wanless IR. Micronodular transformation of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11: 787-797.

11. Kazuhide S, Wanless IR. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 1997; 26: 243-350.

12. Camitta BM. Criteria for severe aplastic anemia. Lancet 1988; 1(8580): 303-4.